Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • AnotherHTS
    Member
    • Aug 2010
    • 11

    #1

    Eland - GRCh37/hg19 assembly

    Hi All,

    I have recently experienced a problem using the human GRCh37/hg19 assembly (from UCSC) with CASAVA/Eland.

    After aligning samples with an expected random coverage to the UCSC GRCh37/hg19 assembly, we noticed large areas with zero read coverage. For example no hits were found between positions 1 and
    151000000 on chr1.

    The fix to this was to place all of the random and unplaced contigs from the assembly into one file before squashing the genome. After we had reduced the number of reference files our alignment ran as expected, and produced the whole genome coverage we expected to see. I was wondering if anyone else has experienced anything similar?
  • mgogol
    Senior Member
    • Mar 2008
    • 197

    #2
    I just did a run against hg19, but I haven't looked at the data yet.

    According to an illumina guy at a user group meeting, you should leave out the haplotype chromosomes when squashing the human genome, otherwise a number of reads will be thrown out for multi-mapping. Also, the genome's too big for squashing if you include them.

    Comment

    • mgogol
      Senior Member
      • Mar 2008
      • 197

      #3
      Just an update: Yes, we did see something similar. Ugh.

      Re-aligning with a genome directly from Illumina that doesn't include the random and unplaced stuff. I really wish eland squash genomes would give you an error when it fails.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      22 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      39 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Working...